(Q37160448)

18 August 2017

1 reference

title

Cannabis, cannabinoids and schizophrenia: integration of the evidence (English)

1 reference

18 August 2017

0 references

0 references

Nadia Solowij

2

0 references

author name string

Martin Cohen

series ordinal

1

1 reference

PubMed ID

18473254

18 August 2017

Vaughan Carr

series ordinal

3

1 reference

18 August 2017

1 May 2008

1 reference

Australian and New Zealand Journal of Psychiatry

18 August 2017

1 reference

18 August 2017

42

1 reference

18 August 2017

5

1 reference

18 August 2017

357-368

1 reference

Adverse effects of cannabis

18 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabis use and psychosis: a review of clinical and epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Effects of smoking marijuana on brain perfusion and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

The residual neuropsychological effects of cannabis: the current status of research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Differential impairments of selective attention due to frequency and duration of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

The residual cognitive effects of heavy marijuana use in college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Neuropsychological performance in long-term cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Acute changes in cerebral blood flow associated with marijuana smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cerebellar activity and disturbed time sense after THC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Neural substrates of faulty decision-making in abstinent marijuana users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Acute marijuana effects on rCBF and cognition: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Brain neuroimaging in cannabis use: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Altered brain tissue composition in heavy marijuana users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabis use and psychosis: a longitudinal population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

The adolescent brain and age-related behavioral manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Specific attentional dysfunction in adults following early start of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

The ecogenetics of schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Intermediate phenotypes and genetic mechanisms of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Tests of causal linkages between cannabis use and psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabis, the mind and society: the hash realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Adverse reactions to marihuana. Classification and suggested treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Psychotogenic drug use and neuroleptic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Substance use among the mentally ill: prevalence, reasons for use, and effects on illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Reasons for substance use in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Patterns of current and lifetime substance use in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Influence of cannabis abuse on schizophrenic psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Anandamide as an intracellular messenger regulating ion channel activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

The molecular logic of endocannabinoid signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Retrograde signaling at GABAA-receptor synapses in the mammalian CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Endocannabinoid signaling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

It could be habit forming: drugs of abuse and striatal synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabis-sensitive dopaminergic markers in postmortem central nervous system: changes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Increased brain dopamine and dopamine receptors in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Getting formal with dopamine and reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Protective activation of the endocannabinoid system during ischemia in dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Pharmacology and behavioral pharmacology of the mesocortical dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Dopamine, the prefrontal cortex and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

A mechanism for generation of long-range synchronous fast oscillations in the cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

A proposed pathological model in the hippocampus of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cell biology of the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

A neurodevelopmental approach to the classification of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Effects of prenatal marijuana on response inhibition: an fMRI study of young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Regulation of a neuronal form of focal adhesion kinase by anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Prenatal stress increases anxiety related behavior and alters cerebral lateralization of dopamine activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Neonatal administration of delta-9-tetrahydrocannabinol (THC) alters the neurochemical response to stress in the adult Fischer-344 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Behavioural consequences of maternal exposure to natural cannabinoids in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

Incidence of schizophrenia in south-east London between 1965 and 1997

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670801961156

10.1080/00048670801961156

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18473254